Skip to main content
. 2017 Jan 6;11(1):e0005270. doi: 10.1371/journal.pntd.0005270

Table 1. Demographics and clinical characteristics of the 75 adults with severe dengue in intensive care units.

Variables All (n = 75) Survivors (n = 44) Non-survivors (n = 31) P value
Age (years) 72.3±9.3 70.8±8.9 74.6±9.4 0.070
Male 46 (61.3) 32 (72.7) 14 (45.2) 0.029
Body weight (kg) 64.9±12.4 67.3±10.7 61.6±14.0 0.064
Underlying disease
 Hypertension 54 (72.0) 35 (79.5) 19 (61.3) 0.117
 Diabetes mellitus 32 (42.7) 18 (40.9) 14 (45.2) 0.814
 Chronic kidney disease 17 (22.7) 8 (18.2) 9 (29.0) 0.281
 Dyslipidemia 16 (21.3) 9 (20.5) 7 (22.6) 1
 Coronary artery disease 14 (18.7) 8 (18.2) 6 (19.4) 1
 Malignancy 11 (14.7) 5 (11.4) 6 (19.4) 0.509
 Stroke 10 (13.3) 7 (15.9) 3 (9.7) 0.509
 Chronic lung disease 7 (9.3) 6 (13.6) 1 (3.2) 0.228
 Heart failure 7 (9.3) 4 (9.1) 3 (9.7) 1
 Liver disease 5 (6.7) 3 (6.8) 2 (6.5) 1
Severe dengue at presentation 61(81.3) 32(72.7) 29(93.5) 0.034
ICU parameters
 APACHE II score 20 [16,28] 17 [13,22] 27 [21,42] <0.001
 SOFA score 11 [7,15] 8 [5,12.8] 16 [11,19] <0.001
Cardiac arrest before ICU admission 7 (9.3) 1 (2.3) 6 (19.4) 0.018
Acute kidney injury at ICU admission 41 (54.7) 18 (40.9) 23 (74.2) 0.005
Renal replacement therapy 12 (16.9) 4 (9.1) 8 (25.8) 0.063
Respiratory failure at ICU admission 47(62.7) 22(50) 25(80.6) 0.008
Mechanical ventilation 57 (76.0) 28 (63.6) 29 (93.5) 0.003
Bloodstream infection 18 (24.0) 8 (18.2) 10 (32.3) 0.180
Blood transfusion 54 (72.9) 30 (68.2) 24 (77.4) 0.441
 Platelets 38 (50.7) 20 (45.5) 18 (58.1) 0.351
 Whole blood 28 (37.3) 14 (31.8) 14 (45.2) 0.333
 Packed red blood cells 37 (49.3) 19 (43.2) 18 (58.1) 0.245
 Plasma 30 (40.0) 14 (31.8) 16 (51.6) 0.099
Hospital course
 ICU stay (days) 6 [3,14] 9 [5.3,15.8] 4 [1,8] <0.001
 Hospital stay (days) 13 [6,23] 20 [11,35.5] 4 [1,8] <0.001

*Data are expressed as case number (%), mean ± standard deviation, or median [inter-quartile range].

APACHE II = acute physiology and chronic health evaluation II; SOFA = sequential organ failure assessment.